Solutions

Clinical drug development for digestive disorders and diseases, such as inflammatory bowel disease and functional GI disorders, presents a unique set of challenges for developing new and effective treatments. Stellixir has extensive experience in conducting gastrointestinal studies across the entire drug development spectrum.

We use typical models to simulate the intestine along with its cell composition, structure, cellular functions, and external environment and replace animal models, including ex vivo, 2D culture, organoid, and 3D culture models. These models evaluate host-microbiome interactions and provide large areas for experiments and high productivity

• Acute Pancreatitis
• Ascites
• Biliary Duct Stenosis
• Colorectal Conditions
• Constipation
• Crohn's Disease
• Liver Cirrhosis
• Exocrine pancreatic insufficiency in cystic fibrosis
• GERD
• Intestinal transit modulation
• Inflammatory Bowel Disease
• Irritable Bowel Disease
• Gastroenteritis Infections
• Pancreatic cancer
• Ulcerative Colitis